Latest Articles

Products coated with a small amount of drug that releases over an extended period of time aren’t suitable for traditional dissolution testing. Therefore, novel drug delivery mechanisms and devices require a new approach to this regulated technique.

In this article, discover the role HPLC plays in ensuring regulatory compliance and reliability of throughput, and how labs can automate to eliminate errors and build reliability into their processes.

In this op-ed article, Michael Kinch explains his optimism around ChatGPT which, in his words, centers around the possibility that we as a society might start to question "claims" and "truths" that we encounter daily.

A revolutionary gene therapy has become a transformative treatment for children with metachromatic leukodystrophy (MLD). But substantial barriers to access for this groundbreaking therapy remain.

In this opinion piece, Vikram Savkar explores the potential impacts of ChatGPT and some of the concerns about the use of the technology.

Electronic pipettes offer several benefits, but many laboratories are still resistant to making the switch from manual options. This article discusses how equipping your team with electronic pipettes could rapidly pay for itself.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

The 11th-hour passage of The FDA Modernization Act gave a much-needed boost to the advocates of new alternative methods (NAMs) for preclinical testing. In this article, we take a look at why NAMs are needed and what the new legislation means for pharmaceutical companies.

Regulators are increasingly collaborating on a global scale, sharing expertise across regions for mutual benefit. In this article, Piety Rocha examines this upward trend.

This article will discuss the principles of fragment-based drug discovery and will highlight some examples of recent successes in this area.